Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H23NO.ClH |
Molecular Weight | 281.821 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
InChI
InChIKey=MWRACNBZNVAJHE-UHFFFAOYSA-N
InChI=1S/C16H23NO.ClH/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14;/h7-10,15H,3-6,11-12H2,1-2H3;1H
Molecular Formula | C16H23NO |
Molecular Weight | 245.3599 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Pyrovalerone is a psychostimulant. It has a central action. Pyrovalerone inhibits the dopamine transporter and the norepinephrine transporter, and is a weak inhibitor of the serotonin transporter. Pyrovalerone was demonstrated to reduce symptoms of chronic fatigue in humans. It stimulated locomotor activity in mice. Though pyrovalerone is still occasionally prescribed, it is used infrequently due to problems with abuse and dependence. Side effects of pyrovalerone include anxiety, fragmented sleep or insomnia and trembling, shaking or muscle tremors.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure. | 2009 Sep 10 |
|
Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. | 2010 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:29:55 UTC 2023
by
admin
on
Fri Dec 15 15:29:55 UTC 2023
|
Record UNII |
Z95Z9C2201
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1485
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
||
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL201960
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
C73830
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
Z95Z9C2201
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
14372
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
1147-62-2
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
m9392
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID70921470
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY | |||
|
214-556-9
Created by
admin on Fri Dec 15 15:29:55 UTC 2023 , Edited by admin on Fri Dec 15 15:29:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |